EPIX Pharmaceuticals, Inc.

EPIX Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing pharmaceutical products to diagnose, treat, and manage patients. It offers drugs to treat various conditions, such as anxiety, depression, Alzheimer's disease, cardiovascular disease, and obesity; and diseases of the central nervous system and lung conditions. EPIX Pharmaceuticals, Inc. was formerly known as EPIX Medical, Inc. and changed its name to EPIX Pharmaceuticals, Inc. in September, 2004. The company was incorporated in 1988 and is based in Lexington, Massachusetts. As of July 20, 2009, EPIX Pharmaceuticals, Inc. is in liquidation.